March 2020 Archives

Homepage
About Us
Services
News Feed
Contact
English
- English
- 中文

Homepage
About Us
Services
News Feed
Contact
English
- English
- 中文

Russian Federation Pharma – March 2020 update

June 8, 2020

Comments are off for this post.

News

Russian Federation Pharma – March 2020 update

KYBORA is an experienced global advisory firm that maintains close direct connections with the top 20 market leaders through regular updates and networking

Recent blog post.

KYBORA Welcomes Vladyslava Bab’yak as an Analyst

Posted: 1 week ago
Podcast: Healthcare Insights by KYBORA

Posted: 2 weeks ago
RODIM Reaches Key Milestones in 2024 Through Strategic Partnership with KYBORA and BPEACE

Posted: 3 weeks ago
Top 10 Challenges Facing CEOs of Biotech Startups and Small/Mid-Sized Biotechs in a Post-2022 World

Posted: 4 weeks ago
KYBORA Welcomes Erik Heinnickel as Senior Director of Operations

Posted: 1 month ago

Tags.

#biopharma Licensing Announcement Bausch Health biopharma biotechnology China Conference Corporate globalhealthcare healthtech Kybora Team LIcensing March 2020 mergersandacquisitions News Priority List Stada license

Tell us about your business and corporate development needs.

Contact Us

KYBORA is a global advisory firm whose mission is to guide transformative healthcare companies to enduring success globally, by offering optimal M&A, licensing, fundraising and strategic advisory services in all key markets around the world.

About Us.

About KYBORA
Meet our team
Success Story
Our Global Presence

Our Services.

M&A
Licensing
Fundraising
Strategic Advisory

Latest News Feed.

KYBORA Welcomes Vladyslava Bab’yak as an Analyst

Posted: 1 week ago
Podcast: Healthcare Insights by KYBORA

Posted: 2 weeks ago

Terms of service | Privacy policy

Recent blog post.

Tags.

TYPE & ENTER: